Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Hepatitis B and Hepatitis C
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
Technavio’s analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• QIAGEN
Other prominent vendors
• Affymetrix
• Allele Biotechnology
• Axis-Shield
• Becton Dickinson
• bioMérieux
• Cepheid
• Chembio Diagnostics
• DiaMetra
• DiaSorin
• Enzo Life Sciences
• Hologic
• ImmunoDX
• MedMira
• OraSure Technologies
• Quest Diagnostics
• Quidel
• Randox Laboratories
• Vela Diagnostics
• Vital Diagnostics
• ZEUS Scientific
Market driver
• Strategies of healthcare organizations toward simplifying the diagnostic process
• For a full, detailed list, view our report
Market challenge
• Regulatory and reimbursement hurdles limit the adoption rate
• For a full, detailed list, view our report
Market trend
• Advent of immunosensors in the HBV and HCV diagnostic tests
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
Technavio’s analysts forecast the global hepatitis B and C diagnostics market to grow at a CAGR of 6.35% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global hepatitis B and C diagnostics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of immunodiagnostics and nucleic acid test (NAT) instruments and consumables to hospitals, diagnostic centers, and research institutes.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hepatitis B and C Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• QIAGEN
Other prominent vendors
• Affymetrix
• Allele Biotechnology
• Axis-Shield
• Becton Dickinson
• bioMérieux
• Cepheid
• Chembio Diagnostics
• DiaMetra
• DiaSorin
• Enzo Life Sciences
• Hologic
• ImmunoDX
• MedMira
• OraSure Technologies
• Quest Diagnostics
• Quidel
• Randox Laboratories
• Vela Diagnostics
• Vital Diagnostics
• ZEUS Scientific
Market driver
• Strategies of healthcare organizations toward simplifying the diagnostic process
• For a full, detailed list, view our report
Market challenge
• Regulatory and reimbursement hurdles limit the adoption rate
• For a full, detailed list, view our report
Market trend
• Advent of immunosensors in the HBV and HCV diagnostic tests
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
